Late Breaking Abstract - Systemic IL-26 correlates with improved asthma control in children with allergic sensitization

M. Kovach (Stockholm, Sweden), U. Käck (Stockholm, Sweden), K. Che (Stockholm, Sweden), B. Levänen (Stockholm, Sweden), G. Lilja (Stockholm, Sweden), J. Konradsen (Stockholm, Sweden), A. Lindén (Stockholm, Sweden)

Source: International Congress 2018 – Molecular and cellular determinants of the developing lung
Session: Molecular and cellular determinants of the developing lung
Session type: Thematic Poster
Number: 1376
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Kovach (Stockholm, Sweden), U. Käck (Stockholm, Sweden), K. Che (Stockholm, Sweden), B. Levänen (Stockholm, Sweden), G. Lilja (Stockholm, Sweden), J. Konradsen (Stockholm, Sweden), A. Lindén (Stockholm, Sweden). Late Breaking Abstract - Systemic IL-26 correlates with improved asthma control in children with allergic sensitization. 1376

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - Efficacy of CSJ117 on allergen-induced asthmatic responses in mild atopic asthma patients
Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Year: 2020




Late Breaking Abstract - Gender and asthma: Gender-dependent effects of obesity on allergic pulmonary inflammation
Source: International Congress 2018 – Notable Studies in Asthma
Year: 2018




Late Breaking Abstract - The effects of allergen (DP/DF) on mucociliary transport of allergic rhinitis patients
Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Year: 2019

Late Breaking Abstract - Formaldehyde inhalation impairs immune system and may affects severity of allergic disease
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017

Late Breaking Abstract - Early response to benralizumab in Canadians with severe eosinophilic asthma
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021


Late Breaking Abstract - Hypoxia dampens the allergen-dependent adaptive immune response and ameliorates allergic asthma in vivo
Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Year: 2021


Late Breaking Abstract: Growing up on a farm leads to lifelong protection against allergic rhinitis
Source: Annual Congress 2010 - Various aspects of respiratory epidemiology
Year: 2010

Late Breaking Abstract - Link between IL-22 and IL-10, IL-13, and severity of symptoms in patients with allergic airway diseases caused by house dust mite
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020


The ’real-life’ long-term efficacy of omalizumab in severe persistent IgE-mediated allergic asthma in Malta
Source: International Congress 2016 – Asthma management
Year: 2016


Systemic cytokine signaling via IL-17 and its relation to clinical characteristics in children with asthma
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015

Adult asthma patients reporting exacerbations triggered by upper airway infection have increased total IgE and sensitization to HDM
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014


Late Breaking Abstract - The impact of treatment with mepolizumab on airway remodeling in patients with severe eosinophilic asthma.
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021


Late Breaking Abstract - Benralizumab treatment strongly reduces blood basophils in patients with severe eosinophilic asthma
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019

Late Breaking Abstract - Clinical characteristics and lung function trends of severe eosinophilic asthma patients unresponsive to Mepolizumab
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019




Late Breaking Abstract - The blood eosinophils count as a predictor of the response for omalizumab (OMA) in patients suffering from severe allergic asthma
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019



Risk factors of incomplete asthma control in asthmatic patients with allergic rhinitis
Source: Annual Congress 2013 –Asthma
Year: 2013


Are acute exacerbation blood eosinophil numbers associated with clinical pattern of preschool wheeze?
Source: International Congress 2015 – More paediatric asthma and allergy
Year: 2015


Induced sputum in children With persistent asthma: The effect to inhaled corticosteroid treatment
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013

Effect of oral corticosteroids on symptomatic reflux in severe allergic asthma: Is there a link?
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


Species comparison of interleukin-13 induced airway hyperreactivity as model for allergic asthma
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014